Abstract
Introduction
Granulomatosis with polyangiitis (GPA), previously known as Wegener granulomatosis, 1 was first reported in the medical literature by McBride 2 in 1897, and its characteristics were further delineated by Klinger 3 and then Wegener himself. 4, 5 It is a rare systemic necrotizing granulomatous vasculitis that primarily affects the upper and lower respiratory tracts and the kidneys. Its reported prevalence approaches 16 in 100,000 population. 6, 7 Sinonasal involvement is the most common manifestation of GPA; it typically presents as recurrent nasal discharge, nasal crusting, epistaxis, and sinus inflammation with associated regional tenderness. [7] [8] [9] In addition to chronic rhinosinusitis (CRS), other common signs include saddle-nose deformity secondary to nasal septal perforation and local bone and cartilage destruction. 10 Additional otolaryngologic manifestations include chronic otitis media, subglottic or tracheal stenosis, and perforation of the palate or pinna.
The hallmark diagnostic finding in GPA is the serologic presence of c-ANCA, which is an IgG autoantibody against cytoplasmic components of polymorphonuclear cells. A lung or kidney biopsy demonstrating the presence of non-necrotizing granulomas is usually indicated to confirm the diagnosis. [11] [12] [13] [14] Treatment is largely medical and is generally divided into an initial induction phase followed by a maintenance phase once remission has been achieved. The induction phase consists of the use of a systemic steroid combined with cyclophosphamide or rituximab, while maintenance treatment consists of an 18-to 24-month course of an oral steroid with azathioprine or methotrexate. 8, 15 An increasing body of evidence suggests that patients with GPA have a significantly higher risk of malignancy than do normal age-matched individuals. [16] [17] [18] [19] One possible explanation for this is the presence of chronic systemic inflammation that leads to carcinogenesis; the prolonged use of chemotherapy, including cyclophosphamide, or immunosuppressant therapy has also been suggested. 19 Specific malignancies that occur at higher rates in GPA patients include bladder carcinoma, lung carcinoma, cutaneous squamous cell carcinoma (SCC), leukemia, and lymphomas. 17 A more rare presentation is a mucosal SCC, including one that involves the sinonasal tract.
In this article, we describe a case of SCC of the nasal cavity in a patient with a long-standing history of GPA. To the best of our knowledge, ours is the fourth such case to be described in the Western literature. 19, 20 We also review the pertinent reports on this topic.
Case report
A 35-year-old man with GPA presented to our head and neck clinic for evaluation of sinonasal symptoms. He had been diagnosed with GPA 15 years earlier and was treated at various intervals with cyclophosphamide, an oral and systemic steroid, mycophenolate, methotrexate, etanercept, and rituximab for sinonasal, pulmonary, and renal involvement. Ten months earlier, he had undergone bilateral revision endoscopic sinus surgery for chronic rhinosinusitis (CRS), and he had previously undergone more than 10 other endoscopic sinus surgeries, all of which had been performed at other institutions.
At the current visit, the patient complained of left-sided orbital and cheek pain and left-sided nasal obstruction. These symptoms had developed since his last endoscopic sinus surgery. Examination found no palpable cervical lymphadenopathy. Office nasal endoscopy detected mucosal edema and polypoid changes bilaterally. Computed tomography (CT) of the sinuses demonstrated a soft-tissue mass in the left nasal cavity with extension through the dehiscent lamina papyracea into the left orbit (figure 1).
Biopsy and examination with the patient under anesthesia was performed. Intraoperatively, a friable, exophytic mass involving the left lateral nasal wall and septum was noted, with extension into the lamina papyracea. Pathologic analysis of specimens obtained during surgery identified a well-differentiated SCC, which was categorized as T4aN0M0.
Thereafter, the patient underwent a combined open and endoscopic left medial maxillectomy for tumor resection. He was counseled on the likely need for orbital exenteration for oncologic control, but he elected for eye preservation regardless of disease extent.
An endoscopic approach was first employed to resect the inferior extent of the tumor. Then, a Lynch incision was used to approach the superior aspect of the tumor, which abutted the orbit. The lamina papyracea, the medial periorbital tissue, and the medial orbital tissue, including the medial rectus muscle, were resected en bloc, and the medial orbit was reconstructed with an absorbable plate. A small focus of disease was left on the globe in respect of the patient's wishes. Postoperatively, he received adjuvant cisplatin with concurrent radiation to the primary site.
Approximately 2 months after the completion of adjuvant therapy, the patient returned to us with increased left orbital pain and swelling. An intranasal biopsy taken at the level of the left ethmoid cavity revealed the presence of a well-differentiated SCC. Magnetic resonance imaging (MRI) of the brain demonstrated a new enhancing lesion of the left frontoethmoid area abutting the cribriform plate, with continued erosion of the left bony orbit (figure 2).
The patient then underwent a craniofacial resection with left orbital exenteration with negative margins, followed by an anterolateral thigh free-flap reconstruction of the resultant tissue and skull base defects. On histopathologic examination, no evidence of perineural, lymphovascular, or bony invasion was seen. The patient underwent another course of radiotherapy with concurrent chemotherapy in an adjuvant setting, and he remained free of disease at 7 months after his last surgery.
Literature review
To review the literature concerning the incidence of SCC in patients with GPA, we searched the MED- 
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LINE database for "squamous cell carcinoma" in conjunction with either "Wegener's granulomatosis" or "granulomatosis with polyangiitis. " The largest number of reports focused largely on the incidence of bladder carcinoma, including both transitional cell carcinomas and SCC. [21] [22] [23] [24] As hypothesized by several authors, this was likely related to the administration of cyclophosphamide, which is well known as an independent risk factor for bladder carcinoma. 25 Other cancers reported to occur at higher frequencies in patients with GPA included cutaneous SCC, leukemia, and lymphomas. 17, 26, 27 We further stratified the MEDLINE query results to include only cases of SCC occurring in the upper aerodigestive tract. This narrowed search found 3 cases in which a patient with GPA was reported to have developed SCC of the oral cavity or oropharynx and 1 case in a patient who had undergone etanercept therapy for GPA. 17, 28 The MEDLINE query also identified 3 cases of SCC arising in the nasal cavity and paranasal sinuses in patients with GPA (table). Wakisaka et al reported the case of a man who had been diagnosed with GPA at the age of 41 years who developed SCC of the nasal septum 14 years later. 19 Stein et al described 2 cases of patients with long-standing GPA who developed SCC of the nasal cavity. 20 One of these patients, who had been diagnosed with GPA at age 24, developed sinonasal SCC 18 years thereafter. The other patient had been diagnosed with GPA at age 21, and he developed sinonasal SCC 24 years later.
Including our patient, the 4 reported cases of sinonasal SCC arising in patients with GPA share several similarities:
• All 4 patients were male, and in each case, more than 10 years had elapsed between the diagnosis of GPA and the diagnosis of SCC.
• All 4 patients had been treated for GPA with cyclophosphamide and both a topical and systemic steroid in addition to other chemotherapeutic and immunosuppressive medications for the amelioration of otolaryngologic and systemic symptoms.
• Finally, all 4 patients presented with sinonasal symptoms that mimicked their earlier symptoms of CRS secondary to GPA, but to a more serious degree.
Discussion
The association between GPA and the development of malignant tumors has been known for decades, but the mechanism of causality remains unclear. 29 While chronic immunosuppression may predispose patients with GPA to develop malignancies, the oncogenic effect of systemic inflammation associated with GPA cannot be understated. 26 In addition, cyclophosphamide has historically remained the mainstay of treatment for GPA, but it has been directly associated with cystitis and the eventual development of bladder carcinoma. 25 Other malignancies encountered in patients with GPA include renal carcinoma, gastrointestinal carcinoma, leukemia, and nonmelanoma skin cancers. 26, 29, 30 As mentioned, 3 cases of SCC arising in the nasal cavity and paranasal sinuses in patients with GPA have been reported previously. 19, 20 We have described the fourth such case. Although our patient had been treated surgically for CRS related to GPA more than a decade earlier, he ultimately presented with SCC involving the left nasal cavity and paranasal sinuses with extension into the orbit.
As is the case with other locally advanced malignancies of the nasal cavity and paranasal sinuses, optimal therapy for SCC involves surgical resection followed by postoperative adjuvant chemoradiotherapy. Our patient exhibited progression of disease 2 months after the completion of adjuvant therapy, and he underwent a salvage craniofacial resection with free-flap reconstruction of the tissue defect, as well as a second round of adjuvant chemoradiation.
All these cases of sinonasal SCC developed many years-at least a decade-after the diagnosis of GPA, and were diagnosed after several years of sinonasal symptoms. This finding lends support to the possibility of a malignancy arising from a long-standing chronic inflammatory process. Also, all 4 patients had been KUAN, peNG, GONzALez, SeRcARz treated with an immunosuppressive agent before the development of SCC, and thus all had at one point been immunocompromised, which further increases the risk of oncogenesis. Finally, in each patient, the harbinger of malignancy was an increase in persistent sinonasal symptoms that were out of proportion to the degree of symptoms that they had previously experienced.
Our case illustrates the importance of the workup of unilateral sinonasal symptoms, since these symptoms can be suggestive of a neoplastic process. 31, 32 The management strategy and clinical outcome of each of these patients has been comparable to those of patients with nasal cavity SCC who were not diagnosed with GPA. It is interesting that in both groups of patients, the diagnosis of malignancy is difficult to discern. GPA patients present with a long-standing history of CRS, and patients without GPA generally present with vague sinonasal complaints.
The management of otolaryngologic and, more specifically, sinonasal manifestations of GPA carries unique challenges. Standard medical therapies for CRS, including topical therapies, as well as endoscopic sinus surgery are routinely employed. However, otolaryngologists must remain cognizant of the fact that GPA confers an increased lifetime risk for malignancies, including those arising in the head and neck. As demonstrated in these 4 cases, any persistent worsening of CRS symptoms, unilateral symptoms, or new orbital findings in a patient with GPA should raise a suspicion of sinonasal malignancy. Rapid diagnosis may aid in ensuring the optimal medical and surgical management of any complications of this complex disease.
